Clinica Internacional, Sede San Borja

Lima Lima 41

0 studies enrolling now · 7 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, First Line Non-Small Cell Lung Cancer, Influenza, Non-Small Cell Lung Cancer, Primary Sjogrens Disease, Urinary Tract Infections, mCRPC

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections — Completed
• Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed